VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+47.84%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$913M
AUM Growth
+$913M
(-37%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
12.62%
Top 10 Holdings %
Top 10 Hldgs %
62.91%
Holding
56
New
8
Increased
8
Reduced
5
Closed
3
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$94.5M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$19.9M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$14.1M |
| 4 |
CMPS
Compass Pathways
CMPS
|
$11.9M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$10.4M |
Top Sells
| 1 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$39.4M |
| 2 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$35.9M |
| 3 |
ASLN
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
|
$4.27M |
| 4 |
Immunic
IMUX
|
$1.59M |
| 5 |
Clene
CLNN
|
$990K |
Sector Composition
| 1 | Healthcare | 99.8% |
| 2 | Consumer Staples | 0.15% |
| 3 | Materials | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
IO Biotech
IOBT
$104M
| $8.7M | 0.95% | 6,173,439 +3,157,894 | +105% | +$4.45M |
|
27
Apogee Therapeutics
APGE
$2.17B
| $8.52M | 0.93% | +400,000 | New | +$8.52M |
|
28
KalVista Pharmaceuticals
KALV
$678M
| $8.24M | 0.9% | 856,008 | – | – |
|
29
Delcath Systems
DCTH
$385M
| $7.51M | 0.82% | 1,855,191 +676,404 | +57% | +$2.74M |
|
30
Savara
SVRA
$567M
| $7.23M | 0.79% | +1,913,349 | New | +$7.23M |
|
31
Compass Therapeutics
CMPX
$483M
| $7.01M | 0.77% | 3,556,023 | – | – |
|
|
ALLK
32
DELISTED
Allakos
ALLK
| $6.78M | 0.74% | 2,988,000 | – | – |
|
|
WHWK
33
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| $6.46M | 0.71% | 509,572 | – | – |
|
34
Aclaris Therapeutics
ACRS
$209M
| $6.16M | 0.67% | 898,631 | – | – |
|
35
Instil Bio
TIL
$182M
| $5.34M | 0.59% | 12,486,787 | – | – |
|
36
Oric Pharmaceuticals
ORIC
$994M
| $4.71M | 0.52% | +777,944 | New | +$4.71M |
|
37
Bolt Biotherapeutics
BOLT
$9.85M
| $4.03M | 0.44% | 3,871,291 | – | – |
|
38
Arrowhead Research
ARWR
$3.05B
| $3.69M | 0.4% | 137,411 | – | – |
|
|
DBVT
39
DBV Technologies
DBVT
$264M
| $3.68M | 0.4% | 2,708,875 | – | – |
|
40
Sera Prognostics
SERA
$123M
| $3.45M | 0.38% | 1,856,011 | – | – |
|
41
Unicycive Therapeutics
UNCY
$74M
| $2.98M | 0.33% | +3,470,152 | New | +$2.98M |
|
42
Iovance Biotherapeutics
IOVA
$807M
| $2.98M | 0.33% | 655,057 | – | – |
|
43
Aligos Therapeutics
ALGS
$73.3M
| $2.65M | 0.29% | 3,547,030 | – | – |
|
44
Fulcrum Therapeutics
FULC
$351M
| $2.31M | 0.25% | 520,000 -30,000 | -5% | -$133K |
|
|
45
Clene
CLNN
$53.1M
| $1.4M | 0.15% | 2,645,338 -1,875,284 | -41% | -$990K |
|
|
IMPL
46
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $1.24M | 0.14% | 2,884,789 | – | – |
|
|
ASLN
47
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $1.07M | 0.12% | 568,182 -2,272,726 | -80% | -$4.27M |
|
48
BioAtla
BCAB
$26.7M
| $908K | 0.1% | 534,181 -103,000 | -16% | -$175K |
|
49
Codexis
CDXS
$246M
| $734K | 0.08% | 388,144 | – | – |
|
50
Rezolute
RZLT
$619M
| $639K | 0.07% | 484,439 -5,034 | -1% | -$6.65K |
|